Biology subjects

Swarup, V.

Publications and source records attributed to Swarup, V..

3 recordsLinked to original sources

bioRxiv2018

Shared gene co-expression networks in autism from induced pluripotent stem cell (iPSC) neurons

BackgroundAutism is a heterogenous collection of disorders with a complex molecular underpinning. Evidence from post-mortem brain studies using adult brains have indicated that early prenatal development may be altered in autism. Induced pluripotent stem cells (iPSCs) generated from autistic individuals with macrocephaly also indicate prenatal development as a critical period for this condition. But little is known about early altered cellular events during prenatal stages in autism. MethodsIPSCs were generated from 9 unrelated autistic individuals without macrocephaly and with heterogeneous genetic backgrounds, and 6 typically developing, control, individuals. IPSCs were differentiated towards either cortical or midbrain fates. Gene expression and high throughput cellular phenotyping was used to characterise iPSCs at different stage of differentiation. ResultsA subset of autism-iPSC cortical neurons were RNA-sequenced to reveal autism-specific signatures similar to post-mortem brain studies, indicating a potential common biological mechanism. Autism-iPSCs differentiated towards a cortical fate displayed impairments in the ability to self-form into neural rosettes. In addition, autism-iPSCs demonstrated significant differences in rate of cell type assignment of cortical precursors, and dorsal and ventral forebrain precursors. These cellular phenotypes occurred in the absence of alterations in cell proliferation during cortical differentiation, differing from previous studies. Acquisition of cell fate during midbrain differentiation was not different between control- and autism-iPSCs. ConclusionsTaken together, our data indicate that autism-iPSCs diverge from control-iPSCs at a cellular level during early stage of neurodevelopment. This suggests that unique developmental differences associated with autism may be established at early prenatal stages.

neuroscience↗

bioRxiv2018

Click-xylosides overcome neurotoxic effects of reactive astrocytes and promote neuronal growth in a cell culture model of brain injury

Astrocytes, upon activation in response to brain injury, play a critical role in protecting neurons by limiting inflammation through the excessive secretion of many soluble factors, such as, chondroitin sulfate proteoglycans (CSPGs). Unfortunately, excessive CSPGs paradoxically prohibit neuronal recovery and growth, and eventually constitute a scar tissue. Many studies have attempted to overcome this barrier through various molecular approaches including the removal of inhibitory CSPGs by applying chondroitinase enzymes. In this study, we examined whether click-xylosides, which serve as primers of glycosaminoglycan (GAG) biosynthesis, can compete with endogenous inhibitory CSPGs for GAG assembly by serving as decoy molecules and thereby potentially reverse reactive astrocyte mediated neuronal growth inhibition. We investigated the axonal growth of hippocampal neurons in the presence of xyloside treated and untreated reactive astrocyte-conditioned media as a model recapitulating brain injury. Click-xylosides were found to interfere with the GAG biosynthetic machinery in astrocytes and reduced the amount of secreted inhibitory CSPGs by competing with endogenous assembly sites. The extent of underglycosylation was directly related to the outgrowth of hippocampal neurons. Overall, this study suggests that click-xylosides are promising therapeutic agents to treat CNS injuries and warrants further in vivo investigations.\n\nO_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=138 SRC=\"FIGDIR/small/286450v1_ufig1.gif\" ALT=\"Figure 1\">\nView larger version (24K):\norg.highwire.dtl.DTLVardef@185db74org.highwire.dtl.DTLVardef@10abd40org.highwire.dtl.DTLVardef@eecadorg.highwire.dtl.DTLVardef@1d48112_HPS_FORMAT_FIGEXP M_FIG C_FIG

neuroscience↗

bioRxiv2017

Inducible and reversible phenotypes in a novel mouse model of Friedreich’s Ataxia

Friedreichs ataxia (FRDA), the most common inherited ataxia, is caused by recessive mutations that reduce the levels of frataxin (FXN), a mitochondrial iron binding protein. We developed an inducible mouse model of Fxn deficiency that enabled us to control the onset and progression of disease phenotypes by the modulation of Fxn levels. Systemic knockdown of Fxn in adult mice led to multiple phenotypes paralleling those observed in human patients across multiple organ systems. By reversing knockdown after clinical features appear, we were able to determine to what extent observed phenotypes represent reversible cellular dysfunction. Remarkably, upon restoration of near wild-type FXN levels, we observed significant recovery of function, associated pathology and transcriptomic dysregulation even after substantial motor dysfunction and pathology were observed. This model will be of broad utility in therapeutic development and in refining our understanding of the relative contribution of reversible cellular dysfunction at different stages in disease.

neuroscience↗